5th Annual
Marie Skłodowska-Curie
Symposium on Cancer Research
and Care
September 3–5, 2025
Conference and Educational Centre
ul. W.K. Roentgena 5,
02-781 Warszawa
Day 1
The 5th Annual Marie Skłodowska-Curie Symposium Opens in Warsaw
Warsaw, September 3, 2025 – The 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care has officially opened, gathering leading oncologists, researchers, and healthcare experts from Europe and the United States. The first day of the three-day meeting was devoted to public health innovations, global cancer strategies, and the application of artificial intelligence in oncology.
The coming days will continue with sessions on breakthroughs in immunotherapy, precision medicine, academia–industry partnerships, and basic cancer research innovations, ensuring a comprehensive and forward-looking exploration of the most pressing issues in global oncology.
With its unique blend of scientific excellence and international cooperation, the Marie Skłodowska-Curie Symposium remains one of the key transatlantic platforms shaping the future of cancer research and care.
Day 2
Day 2 of the 5th Annual Marie Skłodowska-Curie Symposium in Warsaw is behind us!
Yestarday’s sessions showcased groundbreaking advances in immunotherapy and precision medicine, with inspiring discussions on novel clinical trials, molecular profiling, and emerging therapeutic strategies.
The day concluded with a dynamic session on academia–healthcare–biotech collaboration, highlighting how science, policy, and industry can come together to accelerate progress in cancer research and care.
This unique exchange of ideas continues to strengthen the transatlantic bridge shaping the future of oncology.
Day 3
The 5th Annual Marie Skłodowska-Curie Symposium has officially concluded in Warsaw.
The third and final day was devoted to emerging innovations in basic cancer research, including groundbreaking sessions on functional precision oncology and the tumor immuno microenvironment. These discussions offered fresh perspectives on translational science, novel therapeutic targets, and the role of cutting-edge technologies in shaping the future of oncology.
Over the past three days, the Symposium has brought together leading experts from Europe and the United States, creating an exceptional platform for scientific exchange, collaboration, and partnership across academia, healthcare, and industry.
We extend our deepest gratitude to all experts, lecturers, and panelists for sharing their knowledge and insights, as well as to our partners and supporters whose commitment made this meeting possible.
With its unique blend of scientific excellence and international cooperation, the Marie Skłodowska-Curie Symposium continues to serve as a key transatlantic forum driving progress in global cancer research and care.
Photo gallery
Day 1 – September 3rd, 2025
Day 2 – September 4th, 2025
Day 3 – September 5th, 2025
Our mission
Better future for oncology
The symposium aims to promote collaboration among scientists, clinicians, and representatives from the biotechnology and pharmaceutical sectors from the USA, Canada, and Central and Eastern European countries. The event seeks to accelerate the development and testing of new cancer therapies and improve care for oncology patients.
History of the Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care
The Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care was initiated in May 2019 during the 60 Million Congress/Global Polonia Summit in Buffalo. The event aimed to unite scientists, educators, and oncology care specialists from the USA and Poland. After a hiatus due to the COVID-19 pandemic, the second edition took place in September 2022 in a hybrid format, gathering 112 participants from various countries, including Poland, Ukraine, Hungary, the Czech Republic, Croatia, Canada, and the USA. The third edition was held in September 2023 at the Roswell Park Comprehensive Cancer Center in Buffalo, attracting 137 participants from 20 academic institutions and representatives from the biotech and pharmaceutical sectors.
Significance of the Event for International Collaboration
The symposium plays a crucial role in promoting international collaboration among scientists, clinicians, and representatives from the biotechnology and pharmaceutical sectors from the USA, Canada, and Central and Eastern European countries. This collaboration accelerates the development and testing of new cancer therapies and improves care for oncology patients. The event fosters the exchange of knowledge, experiences, and the establishment of lasting scientific and clinical partnerships.
The symposium covers a wide range of topics
related to oncology, including:
- Basic and translational cancer research.
- New therapeutic strategies and innovative treatment methods.
- Early detection and prevention of cancers.
- Biomarker research and clinical applications.
- Challenges and solutions in patient care.
- Health policy and its impact on cancer prevention and treatment.
- Education and training in oncology.
Educational Points
Participation in the Symposium entitles physicians to receive
20 educational points (for confirmed attendance).
Information about the Model:
Year A in Europe, Year B in the USA
Starting from 2025, the symposium adopts a rotational model: in odd-numbered years (Year A), it takes place in Europe, and in even-numbered years (Year B), in the USA. The first European edition will be held in Warsaw from September 3-5, 2025, highlighting Poland’s significance in the international oncology community. The subsequent edition is planned for 2026 in Tampa, Florida.
Who Should Attend?
This symposium is intended for:
- Scientists and researchers in oncology and biotechnology,
- Physicians and healthcare specialists,
- Representatives of the pharmaceutical and biotech industries,
- Policymakers and health organization representatives,
- Students and young scientists interested in oncology.
Call for Abstracts
We warmly invite you to actively participate in the symposium and to submit abstracts highlighting research projects born through international collaboration.
Join us in advancing innovative cancer therapies, early detection strategies, and improved patient care across borders!
Partners
While in Poland
What to see in Poland
We invite you to check the list of places to visit while in Poland during 5th Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care.
Hotels
Where to stay in Warsaw
Please check our propositions for convenient hotels in Warsaw (both walking distance and by metro line).
Address of the Symposium
Educational and Conference Center / Centrum Edukacyjno-Konferencyjne
Maria Sklodowska-Curie National Research Institute of Oncology (NIO-PIB)
ul. W. K. Roentgena 5
02-781 Warszawa
Partner with us in shaping the future of cancer research and care. The MSCS-CRC Symposium offers a unique platform to connect with top oncology professionals, increase your brand’s visibility, and demonstrate your commitment to advancing global health.